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Seventy Escherichia coli isolates recovered from diseased
chickens diagnosed with colibacillosis in Henan Province,
China, between 2004 and 2005 were characterized for
antimicrobial susceptibility profiles via a broth doubling
dilution method. Overall, the isolates displayed resistance
to trimethoprim-sulfamethoxazole (100%), oxytetracycline
(100%), ampicillin (83%), enrofloxacin (83%), and ciprofloxacin
(81%), respectively. Among the phenicols, resistance was
approximately 79% and 29% for chloramphenicol and
florfenicol, respectively. Molecular detection revealed that
the incidence rates of the floR, cmlA, cat1, cat2 and cat3
were 29, 31, 16, 13, and 0%, respectively. Additionally,
10% of the isolates were positive for both floR and cmlA.
As these antimicrobial agents may potentially induce
cross-resistance between animal and human bacterial
pathogens, their prudent use in veterinary medicine is
highly recommended.
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Introduction
Diseases resulting from Escherichia coli (E. coli) infections,
including colibacillosis, air sacculitis, and cellulitis, are
responsible for high morbidity and mortality in poultry, and
these diseases exert a significant economic influence on the
poultry industry [1,6].
Antimicrobials are valuable tools for the treatment of
clinical disease and for the maintenance of healthy, productive
animals. However, recent reports have discovered increased
resistance to the antimicrobial agents commonly utilized for
treatment [1,4,25,27].
Florfenicol, a broad-spectrum antibiotic, belongs to the
family of agents including thiamphenicol and chloramphenicol,
which has played a hugely important role in reducing the
enormous losses in the poultry industry resulting from certain
bacterial diseases, including avian colibacillosis. However,
Kim et al. [21] identified a novel plasmid-encoded gene (pp-
flo) from Photobacterium piscicda in a study conducted in
Japan [21]. More recently, florfenicol resistance conferred
by the floR genes, referred to in the published literature as
pp-flo, cmlA-like, floSt, flo, or floR, has also been detected in
the  Salmonella enteria serovar Typhimurium definitive
phage type (DT) 104 [2,3,8-10,20], Salmonella enterica
serovar Agona [9,14], E. coli [5,7,13,15,16,19,26], Klebsiella
pneumoniae [12], Vibrio cholerae [17] and Pasteurella
multocida  [18], which mediate combined resistance to
florfenicol and chloramphenicol.
Currently, very little data is available regarding the
epidemiology and prevalence of antimicrobial-resistant
veterinary pathogens in domestic animals, particularly in
developing countries, including China, where antimicrobials
are overused in veterinary medicine and domestic animals.
Thus, the principal objective of the present study was to
determine the antimicrobial susceptibility profiles among a
collection of E. coli isolates collected from diseased chickens
that were diagnosed with colibacillosis in China between
2004 and 2005. In addition, due to the high incidence of
emerging florfenicol resistance in tested E. coli isolates 5 to
6 years after its introduction into veterinary clinics and the
limited information regarding phenicol resistance in China,
the resistance determinants for the phenotypes of phenicol
resistance observed in these isolates were identified. The
results presented herein may provide surveillance information
for this specific region.
Materials and Methods
Bacterial strains
70  E. coli isolates were recovered from the livers of
diseased chickens raised on 12 different poultry farms in
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Henan Province, China, from January 2004 to September
2005. All E. coli organisms were isolated and purified on
MacConkey agar and verified as E. coli using the Vitek
system (BioMerieux, USA). The strains were maintained at
−86
oC until analysis. The CVM1841 and CVM827 strains,
which were used as positive controls for the amplification of
the floR and cmlA genes, were kindly donated by Dr. David
White of the FDA, USA. The positive strains harboring the
cat-1,  cat-2 or cat-3  genes were obtained from the
microbiology lab at Henan Agricultural University and were
designated as strain C258, strain C337, and the strain C151,
respectively.
Antimicrobial susceptibility determination
Antimicrobial minimum inhibitory concentrations (MIC)
of the E. coli isolates were determined via the standard broth
doubling dilution method on Muller-Hinton medium, and
were interpreted in accordance with CLSI standards [11].
According to the suggestions provided in a previous report
by Singer et al. [23], florfenicol resistance breakpoints in E.
coli might be defined by an MIC of 32 µg/ml. The following
antimicrobials were tested: ampicillin, ceftiofur, chloramphenicol,
florfenicol, dihydrostreptomycin, gentamicin, amikacin,
kanamycin, enrofloxacin, ciprofloxacin, oxytetracycline,
and trimethoprim/sulfamethoxazole (China Institute of
Veterinary Control, China). E. coli ATCC 25922 was used
as a control in all of the MIC determinations.
Detection of florfenicol and chloramphenicol-resistance
determinants
Genes encoding for florfenicol and chloramphenicol
resistance determinants (floR, cmlA, cat-1, cat-2, and cat-3)
were detected via PCR. Templates of total DNA from each
isolate were prepared as previously described [5]. For the
detection of the floR genes, one pair of the forward primer
(flo1: 5'-GTGTCGTCACATCTACGGCCTTT-3') and the
reverse primer (flo2: 5'-CAGACAGGATACCGACATTC
AC-3') was designed using Oligo 6.0 software on the basis
of the published floR gene sequence [26]. Between the two
primers, the sequence region predicted an 882-bp fragment.
For the positive control, the CVM1841 strain, which harbors
the floR gene, was utilized. PCR was conducted in a final
volume of 50 µl containing 1 µg of template DNA, 100
pmol of each primer (flo1/flo2), 1 × PCR buffer, 0.2 mM of
each dNTP (dATP, dCTP, dGTP, dTTP) and 2.5 U of Ex Taq
polymerase (Takara, Japan). A total of 32 cycles were conducted
in the PCR Express (Thermo Hybaid, UK), under the following
conditions: denaturation at 94
oC for 45 sec, annealing at
62
oC for 45 sec, and an extension step at 72
oC for 1 min.
The primer sets employed in the amplification of cmlA,
cat-1, cat-2, and cat-3  were identical to those previously
described [19,24]. For the amplification of the different
amplicons, the appropriate program parameters were utilized.
The predicted amplicons for the cmlA, cat-1, cat-2, and cat-
3 genes were 699, 585, 495, and 508 bp, respectively. The
CVM827, C258, C337, and C151 strains were utilized as
positive controls for the amplification of the cmlA, cat-1,
cat-2, and cat-3 genes, respectively.
Results
Antimicrobial susceptibility patterns of chicken E. coli
isolates
Seventy E. coli isolates recovered from diseased chickens
diagnosed with colibacillosis were tested for their resistance
to 11 antimicrobial agents
 of human and veterinary therapeutic
significance. The rates of resistance, as determined via
measurements of the MIC and comparisons to the resistance
breakpoints established by CLSI, are listed in Table 1. The
highest rates of resistance were to trimethoprim-sulfamethoxazole
(100%), oxytetracycline (100%), ampicillin (83%), enrofloxacin
(83%), ciprofloxacin (81%), and chloramphenicol (79%),
respectively.
With regard to multidrug resistance profiles, all of the
isolates recovered from the diseased chickens proved
resistant to more than 4 of the 11 tested antimicrobials, 93%
were resistant to more than 8 antimicrobials, and 1% were
resistant to all 11 of the antimicrobials. The majority of E.
coli isolates from this study proved susceptible to ceftiofur
(93%) and amikacin (88%).
Molecular detection of the florfenicol and chloramphenicol
resistant deteminants
The genetic mechanisms relevant to chloramphenicol and
florfenicol resistance in the chicken E. coli isolates were
Table 1. Antimicrobial resistance phenotypes of chicken E. coli
isolates
Class and/or antimicrobial % Resistant strains 
(n = 70)
Phenicols
Chloramphenicol 79
Florfenicol 29
Beta-lactams
Ampicillin 83
Ceftiofur 7
Oxytetracycline 100
Aminoglycosides
Gentamicin 44
dihydrostreptomycin 42
Amikacin 12
Potentiated sulfonamides
Trimethoprim-sulfamethoxazole 100
Fluoroquinolones
Enrofloxacin 83
Ciprofloxacin 81Molecular detection of chloramphenicol and florfenicol resistance among  E. coli 245
evaluated for the presence of 5 genes recognized to confer
resistance to these antimicrobials: cmlA, cat-1, cat-2, cat-3,
and floR. The different amplification products for the genes
encoding for florfenicol and chloramphenicol resistance
determinants are provided in Fig. 1. Using the total genomic
DNA from each of the seventy chloramphenicol-resistant
isolates as the PCR template, fifteen E. coli isolates (21.4%)
were found to be positive for the cmlA gene and thirteen E.
coli isolates (18.6%) were positive for the floR gene, with 20
of these isolates (28.6%) also harboring one of the
chloramphenicol acetyltransferase genes (cat-1 or cat-2)
(Table 2). Additionally, seven E. coli isolates (10%) were
found to be positive for both the floR and
 cmlA genes, and
both florfenicol and chloramphenicol MICs for these
isolates were elevated (≥64 µg/ml) (Table 2).
Fig. 1. Amplification of genes encoding for florfenicol and chloramphenicol resistance determinants. (A) The amplification of the  floR
genes. Lane 1: Marker; Lane 2: The negative isolate; Lane 3: The positive isolate; Lane 4: The positive control (B) The amplifi cation of
the cmlA genes. Lane 1: Marker; Lane 2-3: The positive isolate; Lane 4: The positive control. (C) The amplification of the  cat-1 genes.
Lane 1: Marker; Lane 2: The positive isolate; Lane 3-4: The negative isolates. (D) The amplification of the  cat-2 genes. Lane 1: Marker;
Lane 2-3: The positive isolate; Lane 4: The positive control.
Table 2. Prevalence of cmlA, cat-1, cat-2 and floR genes in chloramphenicol-resistant chicken E. coli
Resistance genotype
MIC (µg/ml) No. of (%) isolates positive for 
resistance genes chloramphenicol florfenicol
cat-1 ≥32 2~16 11/70 (15.7)
cat-2 ≥32 2~16 09/70 (12.9)
cmlA ≥32 2~16 15/70 (21.4)
floR ≥32 ≥32 13/70 (18.6)
cmlA, floR ≥64 ≥64 07/70 (10.0)246 Xin-Sheng Li et al.
Discussion
The bacterial isolates assessed in this study displayed similar
levels of resistance to oxytetracycline, ampicillin, norfloxacin,
and ciprofloxacin as were previously reported for E. coli
strains isolated from diseased chickens in China by Yang  et al.
[27]. However, the chloramphenicol resistance rate (79%)
determined in this study was significantly higher than that
reported in the same country (24%), and this may reflect
different patterns of antimicrobial use in different regions. In
addition, as compared to the data from the only other report
concerning florfenicol resistance in chicken E. coli isolates by
Keyes et al. [19], the chicken E. coli isolates evaluated in this
study displayed elevated resistance levels (Table 1).
Due to the wide use of oxytetracycline, sulfonamides,
chloramphenicol, and fluoroquinolones for the treatment
and prevention of diseases in chickens over the past decade,
it was expected that the E. coli strains recovered from
diseased chickens diagnosed with colibacillosis in this study
would displayed a high rate of resistance to these drugs, and
that was indeed the case. However, the high incidence of
florfenicol resistance in the E. coli isolates tested herein was
somewhat unexpected, as this drug was introduced into
veterinary clinics for use in China only 6 to 7 years ago. This
finding suggests that the selection pressure of chloramphenicol,
as well as the other antimicrobials, may perform a relevant
role in the emergence and dissemination of florfenicol
resistance in E. coli.
Antimicrobials are useful therapeutic agents only if the
drug concentrations achieved in the serum and tissue exceed
the MIC of the drug. Based on this principle, Keyes et al.
[19] suggested that florfenicol may not be therapeutically
successful in some cases, as pharmacokinetic studies have
demonstrated that the peak plasma florfenicol concentration
in broiler chickens following oral administration of 15 mg/
kg body weight is approximately 4 µg/ml. The florfenicol-
resistant chicken E. coli isolates observed in both that study
and the present study displayed florfenicol MICs in excess
of that amount [19,22]. In this study, we also noted that 29
percent of the total isolates displayed florfenicol MICs in
excess of 32 µg/ml. In order to ensure the rational and
effective use of this drug, the expanded veterinary use of this
drug in the treatment of E. coli-related chicken diseases can
not be recommended at this time.
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